Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in First Episode Pediatric Nephrotic Syndrome
NCT04783675Phase 2Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Apr 2021
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in nephrotic syndrome, sponsored by Children's Hospital of Fudan University. Started Apr 2021; status: completed.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT04783675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04783675.